The customer is a pharmaceutical manufacturer that has evaluated NLAB Saga® on a small scale and has now placed an order for production.
“In
“As we announced earlier this week, our large-scale silica production facility is now delivering significantly larger volumes than before. How much more that will land as sales in the second quarter remains to be seen, but with an increasing stock of finished goods, we are able to deliver faster on this and future orders, which means that we can increase our sales efforts ”, CEO
© Modular Finance, source